Long-term safety of TQH2722 for chronic sinusitis with or without polyps
Part of Ear, nose & throat clinical trials.
This study checks the long-term safety and effectiveness of a new injection called TQH2722 for people with chronic sinusitis (with or without nasal polyps) who have already taken part in an earlier TQH2722 trial. It aims to see if the drug continues to help over a longer period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in the previous TQH2722 study for chronic sinusitis (with or without nasal polyps) and either completed it or left early for reasons not related to the drug's side effects.
- You need to be between 18 and 75 years old.
- You must have been using a steady dose of a steroid nasal spray for at least 4 weeks, and be willing to switch to mometasone if you were using a different type.
- You must not have any unstable or serious health problems, like uncontrolled heart disease, high blood pressure, or diabetes.
- If you have asthma, it must be well-controlled and you cannot be taking very high doses of inhaled steroids.
- You cannot be pregnant, breastfeeding, or planning to have children during the study; you must use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if using a nebulizer to deliver steroid spray can help people with chronic sinusitis (CRS) without prior sinus surgery. It focuses on improving symptoms like nasal congestion and facial pressure.
This study tests a new drug called BBT002 in healthy people and in patients with chronic sinusitis and nasal polyps, with or without asthma. It aims to see if the drug is safe and effective for reducing symptoms.
This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.
This study tests a new medicine called CM326 for people with chronic sinusitis and nasal polyps (growths in the nose). It may help if you still have symptoms despite using steroid sprays or if you cannot take steroids.
This trial tests an injection called LP-003 for people with nasal polyps and chronic sinusitis. It aims to reduce symptoms like nasal congestion and improve quality of life. You may qualify if you have tried other treatments and still have symptoms.
This trial tests a nasal spray called VVN432 in healthy volunteers and people with chronic sinusitis. It checks if the spray is safe and how the body processes it.
Hear when a new Chronic Rhinosinusitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.